1. Home
  2. SIEB vs LUNG Comparison

SIEB vs LUNG Comparison

Compare SIEB & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Siebert Financial Corp.

SIEB

Siebert Financial Corp.

HOLD

Current Price

$1.67

Market Cap

68.0M

Sector

Finance

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$2.28

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIEB
LUNG
Founded
1886
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.0M
57.9M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
SIEB
LUNG
Price
$1.67
$2.28
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$5.38
AVG Volume (30 Days)
14.4K
705.3K
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.64
EPS
N/A
N/A
Revenue
$94,202,000.00
$90,497,000.00
Revenue This Year
N/A
$2.48
Revenue Next Year
N/A
$18.46
P/E Ratio
N/A
N/A
Revenue Growth
12.28
8.01
52 Week Low
$1.53
$1.13
52 Week High
$4.15
$2.89

Technical Indicators

Market Signals
Indicator
SIEB
LUNG
Relative Strength Index (RSI) 49.53 75.73
Support Level $1.55 $2.16
Resistance Level $1.75 $2.39
Average True Range (ATR) 0.06 0.20
MACD 0.01 0.09
Stochastic Oscillator 63.68 92.89

Price Performance

Historical Comparison
SIEB
LUNG

About SIEB Siebert Financial Corp.

Siebert Financial Corp is a diversified financial services firm engaged in providing brokerage and financial advisory services. The coperates through two segments: Financial Services and Media, Sports and Entertainment. The Financial Services segment mainly operates as a securities broker-dealer and provides brokerage, custody, and clearing services for retail accounts, as well as insurance and advisory services, principal and proprietary trading, market making, securities lending, and investment banking and capital markets services. The Media, Sports and Entertainment segment is engaged in the production and distribution of music and media content, as well as talent management and sports representation. It generates the majority of its revenue from the Financial Services segment.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: